2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Behçet Disease: new trials by email Literature Review of Behçet Disease trials Research Report on Behçet Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dusquetide for the Treatment of Behcet's Disease Dusquetide - Behçet Disease | Phase 2 | Completed | Soligenix | 8 | 2024-11-18 | 2026-08-26 |
| A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease Hemay005, Placebo - Behçet Disease | Phase 2 | Terminated | Tianjin Hemay Pharmaceutical Co., Ltd | 89 | 2020-11-30 | 2022-06-21 |
| Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease Subcutaneous Ustekinumab - Behçet Disease | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2017-06-14 | 2025-09-08 |
Behcet Syndrome (3) · Ulcer (1) · Uveitis (1)
Cardiovascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Eye Diseases (3) · Genetic Diseases, Inborn (3) · Hereditary Autoinflammatory Diseases (3) · Mouth Diseases (3) · Panuveitis (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Stomatognathic Diseases (3) · Uveal Diseases (3) · Uveitis, Anterior (3) · Vascular Diseases (3)
Cyclic Nucleotide Phosphodiesterases, Type 4 (1) · Hemay005 (1) · dusquetide (1)
Assistance Publique - Hôpitaux de Paris (1) · Soligenix (1) · Tianjin Hemay Pharmaceutical Co., Ltd (1)
China (1) · France (1) · Turkey (Türkiye) (1)